Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
- To evaluate the superiority in the efficacy of HMR1964 and OHA combination therapy as
compared with OHA therapy.
- To evaluate the superiority in the efficacy of HMR1964 mono-therapy as compared with OHA
therapy.
- To evaluate the safety of HMR1964.